To identify mechanisms that underlie the opposing effects that IGFBP-3 has in breast cancer, the expression of IGFBP-3 was measured in cell line models of ERα positive and triple-negative breast cancer (TNBC) cells. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.